No studies have evaluated BPC-157 in cancer models specifically, which is a gap, not a reassurance
The good news is that neuroinflammation is a big deal in central nervous system diseases, and benefits from fighting it in those diseases may very well accrue to people with ME/CFS and FM
Overall, there was no significant change in GSH, GSH:GSSG or behaviour
The FDA removed BPC-157 from the list of substances that can be used by compounding pharmacies specifically, its no longer on the 503A or 503B bulk drug substance lists that allow compounders to make non-FDA-approved drugs legally
OTHER INGREDIENTS: Dicalcium Phosphate, Vegetarian Capsule (hypromellose and water), Magnesium Stearate
Capsule Dosage Chart Dosage & Protocols Variations BPC-157 Capsules supply 500 mcg per capsule (bottles of 30 or 60), dosed in whole-capsule increments and taken orally with water